Dianne C. Whitfield Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity

Dianne C. Whitfield is Chief Human Resources Officer of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 23,393 shares of TARS, which is worth approximately $1.69 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 15,565 shares (Common Stock) at a price of $81.41 per share, resulting in proceeds of $1,267,146. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.4K

49.54% 3M change

31.56% 12M change

Total Value Held $1.69 Million

Dianne C. Whitfield Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 02 2026	SELL Open market or private sale	$1,267,146 $81.41 p/Share	15,565 Reduced 39.95%	23,393 Common Stock
Dec 16 2025	SELL Open market or private sale	$592,499 $80.1 p/Share	7,397 Reduced 15.96%	38,958 Common Stock
Mar 20 2025	SELL Open market or private sale	$107,085 $50.11 p/Share	2,137 Reduced 4.41%	46,355 Common Stock
Mar 19 2025	SELL Open market or private sale	$107,076 $47.4 p/Share	2,259 Reduced 4.45%	48,492 Common Stock
Mar 18 2025	SELL Open market or private sale	$107,161 $46.29 p/Share	2,315 Reduced 4.36%	50,751 Common Stock
Mar 15 2025	BUY Exercise of conversion of derivative security	-	18,885 Added 26.25%	53,066 Common Stock
Mar 18 2024	SELL Open market or private sale	$132,008 $30.6 p/Share	4,314 Reduced 11.21%	34,181 Common Stock

Mar 15 2024	BUY Exercise of conversion of derivative security	-	11,711 Added 23.33%	38,495 Common Stock
Nov 30 2023	SELL Open market or private sale	$136,270 $16.31 p/Share	8,355 Reduced 23.78%	26,784 Common Stock
Nov 29 2023	BUY Exercise of conversion of derivative security	-	23,920 Added 40.5%	35,139 Common Stock
Mar 23 2023	SELL Open market or private sale	$4,191 $12.15 p/Share	345 Reduced 2.98%	11,219 Common Stock
Mar 22 2023	SELL Open market or private sale	$4,209 $12.64 p/Share	333 Reduced 2.8%	11,564 Common Stock
Mar 21 2023	SELL Open market or private sale	$4,202 $12.89 p/Share	326 Reduced 2.67%	11,897 Common Stock
Mar 20 2023	SELL Open market or private sale	$4,199 $12.61 p/Share	333 Reduced 2.65%	12,223 Common Stock
Mar 17 2023	SELL Open market or private sale	$4,196 $13.28 p/Share	316 Reduced 2.45%	12,556 Common Stock
Mar 16 2023	SELL Open market or private sale	$4,203 $13.43 p/Share	313 Reduced 2.37%	12,872 Common Stock
Mar 15 2023	BUY Exercise of conversion of derivative security	-	4,462 Added 25.28%	13,185 Common Stock
Dec 02 2022	SELL Open market or private sale	$19,502 $16.9 p/Share	1,154 Reduced 11.68%	8,723 Common Stock
Dec 01 2022	SELL Open market or private sale	$19,513 $16.75 p/Share	1,165 Reduced 10.55%	9,877 Common Stock
Nov 30 2022	SELL Open market or private sale	$19,503 $16.5 p/Share	1,182 Reduced 9.67%	11,042 Common Stock
Nov 29 2022	BUY Exercise of conversion of derivative security	-	10,251 Added 45.61%	12,224 Common Stock

DCW

Dianne C. Whitfield

Chief Human Resources Officer

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Value

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS

Account